Switch to
More onapp

How to use scorecard? Learn more

Brooks Laboratories Ltd

BROOKS
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹411 cr, stock is ranked 2,000
High RiskStock is 4.13x as volatile as Nifty
159.993.13 (+2.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹411 cr, stock is ranked 2,000
High RiskStock is 4.13x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
-20.33
PB RatioPB Ratio
6.15
Dividend YieldDiv. Yield
Sector PESector PE
51.92
Sector PBSector PB
6.65
Sector Div YldSctr Div Yld
0.51%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Brooks Laboratories Ltd. is a Contract Manufacturing Company. The Company manufacturers molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Financial TrendFinancial statements 

202120222023202477.9991.9863.7780.45-19.36-11.30-20.90-19.58
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Copy of Newspaper Publication 
Announced OnDec 20, 2024

Brooks Laboratories Limited has informed the Exchange about Copy of Newspaper Publication relating to the dispatch of EOGM Notice along with E-voting details | Download

Brooks Laboratories Limited has informed the Exchange about Copy of Newspaper Publication relating to the dispatch of EOGM Notice along with E-voting details | Download

Shareholders meeting 
Announced OnDec 19, 2024

Brooks Laboratories Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on January 11, 2025 | Download

Brooks Laboratories Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on January 11, 2025 | Download

Preferential issue 
Announced OnDec 18, 2024

Brooks Laboratories Limited has informed the Exchange about Preferential issue | Download

Brooks Laboratories Limited has informed the Exchange about Preferential issue | Download

See all events